These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction. Abdulla J; Abildstrom SZ; Christensen E; Kober L; Torp-Pedersen C Eur J Heart Fail; 2004 Dec; 6(7):927-35. PubMed ID: 15556055 [TBL] [Abstract][Full Text] [Related]
5. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors. Chow MS Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997 [TBL] [Abstract][Full Text] [Related]
6. [Vasodilators in heart failure. Basis for their use]. Mesquita ET; Mady C Arq Bras Cardiol; 1994 Dec; 63(6):531-6. PubMed ID: 7605242 [No Abstract] [Full Text] [Related]
7. Congestive heart failure: what should be the initial therapy and why? Chatterjee K Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993 [TBL] [Abstract][Full Text] [Related]
8. The management of chronic heart failure. Cohn JN N Engl J Med; 1996 Aug; 335(7):490-8. PubMed ID: 8672155 [No Abstract] [Full Text] [Related]
9. Current and novel pharmacologic approaches in advanced heart failure. O'Connor CM; Gattis WA; Swedberg K Am Heart J; 1998 Jun; 135(6 Pt 2 Su):S249-63. PubMed ID: 9630089 [No Abstract] [Full Text] [Related]
10. [Present status of drug therapy in chronic heart dysfunction]. Sato T Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):354-9. PubMed ID: 7751768 [No Abstract] [Full Text] [Related]
11. [Treatment of heart failure: what--when--how?]. Blömer H Verh Dtsch Ges Inn Med; 1990; 96():157-67. PubMed ID: 2092435 [No Abstract] [Full Text] [Related]
12. Heart failure syndrome. Rationale for current drug treatment. Burkart F Eur Heart J; 1995 Jul; 16 Suppl F():2-3. PubMed ID: 8521880 [TBL] [Abstract][Full Text] [Related]
13. Left ventricular dysfunction and heart failure. Mechanistic and therapeutic distinctions. Cohn JN Clin Exp Hypertens; 1996; 18(3-4):559-68. PubMed ID: 8743043 [TBL] [Abstract][Full Text] [Related]
17. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?]. Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706 [No Abstract] [Full Text] [Related]
18. [Mildronate in combined treatment of chronic cardiac insufficiency]. Nedoshivin AO; Kutuzova AE; Perepech NB Klin Med (Mosk); 1999; 77(3):41-3. PubMed ID: 10234947 [No Abstract] [Full Text] [Related]
19. Mechanisms and how to treat heart failure. Sonnenblick EH; Burkart F; Julian GD; Just H; Kubler W; Rutishauser W Am J Med; 1989 Dec; 87(6B):96S-98S. PubMed ID: 2603889 [No Abstract] [Full Text] [Related]
20. [Pharmacologic interactions with nitrates in patients with, or at risk of, cardiac decompensation]. Filardi PP; Chiariello M G Ital Cardiol; 1996 Sep; 26(9):1085-8. PubMed ID: 9036050 [No Abstract] [Full Text] [Related] [Next] [New Search]